February 23, 2024
You are here:  Home  >  Columns  >  Current Article

Dubroff: Diversity remains key to Amgen’s central goals in biotech


Henry Dubroff
When I first wrote about the Amgen Biotech Experience, it was in the process of rolling out LabXchange, an innovative approach using virtual platforms to transform science education and open the field to a more diverse generation of students. This month the program took another step forward with new funding that will bring the Biotech…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.